title: Etanercept for the treatment of severe childhood psoriasis.
authors.forename: M
authors.initials: M
authors.lastname: Papoutsaki
authors.forename: A
authors.initials: A
authors.lastname: Costanzo
authors.forename: A
authors.initials: A
authors.lastname: Mazzotta
authors.forename: T
authors.initials: T
authors.lastname: Gramiccia
authors.forename: R
authors.initials: R
authors.lastname: Soda
authors.forename: S
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000293:Adolescent; D002648:Child; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000068800:Etanercept